Concepedia
4
Publications
127
Citations
H-Index
2021
Active since
Affiliations
United States Food and Drug Administration(Current)
Center for Biologics Evaluation and Research
IBM (United States)
Acumen (United States)
Keran Moll is an author at United States Food and Drug Administration.
Publications per year
2021–2022
Validating Claims-Based Algorithms Determining Pregnancy Outcomes and Gestational Age Using a Linked Claims-Electronic Medical Record Database
Keran Moll, Hui Lee Wong, Kathryn R. Fingar et al. · Drug Safety · 2021 · 64 citations · Full text
Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019–2020
Keran Moll, Bradley Lufkin, Kathryn R. Fingar et al. · Vaccine · 2022 · 34 citations · Full text
Vaccine exposure during pregnancy among privately and publicly insured women in the United States, 2016–2018
Keran Moll, Hui‐Lee Wong, Kathryn R. Fingar et al. · Vaccine · 2021 · 19 citations · Full text
Assessment of performance characteristics of COVID-19 ICD-10-CM diagnosis code U07.1 using SARS-CoV-2 nucleic acid amplification test results
Keran Moll, Shayan Hobbi, Cindy Ke Zhou et al. · PLoS ONE · 2022 · 10 citations · Full text
Rows per page
1–4 of 4